跳至主要内容
临床试验/CTRI/2025/11/096779
CTRI/2025/11/096779尚未招募不适用

A RANDOMISED TWO ARM ACTIVE CONTROLLED CLINICAL STUDY OF GASTRO ESOPHAGEAL REFLUX DISEASE (MARZ-E-INEKAS-E-HUMUZAT-E-MEDA WO MARI ) WITH COMPOUND UNANI FORMULATION JAWARISH-E-TABASHEER AND RABEPRAZOLE

PG Scholar Dept of Moalijat1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年11月15日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
试验地点
1
主要终点
to evaluate the clinical efficacy of jawarish e tabasheer in cases of GERD

研究概览

简要总结

GERD (Gastroesophageal Reflux Disease):

GERD is a chronic condition where stomach acid frequently flows back into the esophagus, causing irritation and inflammation. This occurs due to weakness or relaxation of the lower esophageal sphincter (LES).

Key Symptoms are :-Heartburn (burning chest pain), Regurgitation of food or sour fluid, Bloating, belching, Difficulty swallowing, Chronic cough or sore throat

Jawarish-e-Tabasheer is a classical Unani formulation traditionally used for strengthening the digestive system and reducing excess heat and bile (Safra).

Since the  chronic use of PPIs in the management of GERD cause hypomagnesemia,osteoporosis ;the efficacy of unani drug JAWARISH E TABASHEER is evaluated

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patient of either sex Age : 20-60 years.
  • Patient with following complains :Regurgitation, Heart burn, Epigastric Pain,Nausea ,Indigestion,Flatulence,Loss of appetite, Water brash, Heaviness in abdomen after meals.

排除标准

  • Pregnant and lactating women Psychiatric patients Uncontrolled diabetes GERD due to LOS causes .
  • Patients with cardiac, respiratory, liver and renal dysfunction.
  • Patients with: Bleeding disorders Known peptic ulcers Gastric carcinoma Hiatus hernia Crohn’s disease Zollinger Ellison Syndrome Esophageal strictures, stenosis Other malignancies.

结局指标

主要结局

to evaluate the clinical efficacy of jawarish e tabasheer in cases of GERD

时间窗: once in 2-4 weeks

次要结局

  • To prevent from complications of GERD like peptic strictures, Barret’s esophagus, esophageal adenocarcinoma.(Once in Two weeks)

研究者

发起方
PG Scholar Dept of Moalijat
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Amreen

Government Nizamia Tibbi College and Hospital

研究点 (1)

Loading locations...

相似试验

Clinical study to evaluate the efficacy of COMPOUND... | 临床试验